Vault-13

First Turn Management, LLC

DEL MAR, CA · CIK 1993440 · 13F filing filed 2025-11-14

SEC-registered investment adviser since 2023 · limited liability company

As an employer

$666.0m reported value +24.2% vs Q2 2025
29positions
51.5%in top 10
7 new 17 added 5 reduced 13 sold out vs Q2 2025

Holdings, Q3 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 INSMED INC COM PAR $.01 INSM INSM 319,773 $46.1m6.91% 6.91% ReducedShares held: Q4 2024 447.0k, Q1 2025 401.6k, Q2 2025 372.7k, Q3 2025 319.8k -52.9k -52,899 -14.2%
2 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 570,569 $41.8m6.28% 6.28% AddedShares held: Q4 2024 506.9k, Q1 2025 503.0k, Q2 2025 527.5k, Q3 2025 570.6k +43.0k +43,029 8.2%
3 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 85,318 $35.8m5.37% 5.37% NewShares held: Q4 2024 0, Q1 2025 0, Q2 2025 0, Q3 2025 85.3k
4 MERUS N V COM MRUS MRUS 372,022 $35.0m5.26% 5.26% AddedShares held: Q4 2024 285.2k, Q1 2025 464.0k, Q2 2025 293.0k, Q3 2025 372.0k +79.1k +79,058 27.0%
5 NUVALENT INC COM COM 394,754 $34.1m5.13% 5.13% AddedShares held: Q4 2024 309.5k, Q1 2025 331.9k, Q2 2025 320.8k, Q3 2025 394.8k +74.0k +73,956 23.1%
6 XENON PHARMACEUTICALS INC COM XENE XENE 799,743 $32.1m4.82% 4.82% AddedShares held: Q4 2024 685.0k, Q1 2025 683.5k, Q2 2025 660.6k, Q3 2025 799.7k +139.1k +139,126 21.1%
7 BRIDGEBIO PHARMA INC COM BBIO BBIO 589,729 $30.6m4.60% 4.60% AddedShares held: Q4 2024 452.3k, Q1 2025 656.7k, Q2 2025 551.7k, Q3 2025 589.7k +38.0k +38,045 6.9%
8 REVOLUTION MEDICINES INC COM RVMD RVMD 643,050 $30.0m4.51% 4.51% AddedShares held: Q4 2024 403.9k, Q1 2025 340.1k, Q2 2025 415.6k, Q3 2025 643.0k +227.5k +227,459 54.7%
9 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 146,291 $29.1m4.37% 4.37% AddedShares held: Q4 2024 87.8k, Q1 2025 113.3k, Q2 2025 134.7k, Q3 2025 146.3k +11.6k +11,604 8.6%
10 ARGENX SE SPONSORED ADR ARGX ARGX 38,767 $28.6m4.29% 4.29% ReducedShares held: Q4 2024 43.1k, Q1 2025 41.9k, Q2 2025 44.0k, Q3 2025 38.8k -5.2k -5,186 -11.8%
11 DISC MEDICINE INC COM IRON IRON 397,693 $26.3m3.95% 3.95% AddedShares held: Q4 2024 0, Q1 2025 0, Q2 2025 299.5k, Q3 2025 397.7k +98.2k +98,229 32.8%
12 ORIC PHARMACEUTICALS INC COM ORIC ORIC 2,159,474 $25.9m3.89% 3.89% AddedShares held: Q4 2024 1.5m, Q1 2025 2.0m, Q2 2025 2.0m, Q3 2025 2.2m +149.6k +149,551 7.4%
13 ARCELLX INC COMMON STOCK ACLX ACLX 313,733 $25.8m3.87% 3.87% AddedShares held: Q4 2024 152.4k, Q1 2025 0, Q2 2025 215.2k, Q3 2025 313.7k +98.5k +98,510 45.8%
14 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 181,897 $25.5m3.83% 3.83% NewShares held: Q4 2024 0, Q1 2025 0, Q2 2025 0, Q3 2025 181.9k
15 ABIVAX SA SPONSORED ADS ABVX ABVX 291,820 $24.8m3.72% 3.72% NewShares held: Q4 2024 0, Q1 2025 0, Q2 2025 0, Q3 2025 291.8k
16 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 716,971 $20.4m3.06% 3.06% AddedShares held: Q4 2024 0, Q1 2025 0, Q2 2025 521.1k, Q3 2025 717.0k +195.9k +195,874 37.6%
17 AKERO THERAPEUTICS INC COM AKRO AKRO 397,010 $18.9m2.83% 2.83% AddedShares held: Q4 2024 0, Q1 2025 0, Q2 2025 114.6k, Q3 2025 397.0k +282.5k +282,456 246.6%
18 AXSOME THERAPEUTICS INC COM AXSM AXSM 152,614 $18.5m2.78% 2.78% AddedShares held: Q4 2024 192.1k, Q1 2025 118.2k, Q2 2025 144.4k, Q3 2025 152.6k +8.2k +8,214 5.7%
19 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 783,411 $16.0m2.41% 2.41% AddedShares held: Q4 2024 535.1k, Q1 2025 535.1k, Q2 2025 510.0k, Q3 2025 783.4k +273.4k +273,424 53.6%
20 APOGEE THERAPEUTICS INC COM COM 402,811 $16.0m2.40% 2.40% AddedShares held: Q4 2024 252.7k, Q1 2025 229.7k, Q2 2025 311.5k, Q3 2025 402.8k +91.3k +91,321 29.3%
21 KYMERA THERAPEUTICS INC COM KYMR KYMR 277,726 $15.7m2.36% 2.36% NewShares held: Q4 2024 0, Q1 2025 0, Q2 2025 0, Q3 2025 277.7k
22 JANUX THERAPEUTICS INC COM JANX JANX 639,699 $15.6m2.35% 2.35% AddedShares held: Q4 2024 383.6k, Q1 2025 430.2k, Q2 2025 447.4k, Q3 2025 639.7k +192.3k +192,279 43.0%
23 ROIVANT SCIENCES LTD SHS ROIV ROIV 959,703 $14.5m2.18% 2.18% NewShares held: Q4 2024 0, Q1 2025 0, Q2 2025 0, Q3 2025 959.7k
24 CYTOKINETICS INC COM NEW CYTK CYTK 254,795 $14.0m2.10% 2.10% NewShares held: Q4 2024 0, Q1 2025 0, Q2 2025 0, Q3 2025 254.8k
25 NATERA INC COM NTRA NTRA 80,875 $13.0m1.95% 1.95% ReducedShares held: Q4 2024 99.2k, Q1 2025 139.9k, Q2 2025 118.1k, Q3 2025 80.9k -37.3k -37,255 -31.5%
26 ADMA BIOLOGICS INC COM ADMA ADMA 808,673 $11.9m1.78% 1.78% ReducedShares held: Q4 2024 684.2k, Q1 2025 566.9k, Q2 2025 1.1m, Q3 2025 808.7k -283.7k -283,688 -26.0%
27 VERA THERAPEUTICS INC CL A VERA VERA 354,529 $10.3m1.55% 1.55% AddedShares held: Q4 2024 464.8k, Q1 2025 623.6k, Q2 2025 309.7k, Q3 2025 354.5k +44.9k +44,863 14.5%
28 HARROW INC COM HROW HROW 160,234 $7.7m1.16% 1.16% ReducedShares held: Q4 2024 304.9k, Q1 2025 188.8k, Q2 2025 228.8k, Q3 2025 160.2k -68.5k -68,527 -30.0%
29 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 262,643 $1.9m0.28% 0.28% NewShares held: Q4 2024 0, Q1 2025 179.2k, Q2 2025 0, Q3 2025 262.6k

Sold out since Q2 2025

SecurityTickerShares held beforeValue then
VERONA PHARMA PLC VRNA VRNA 309,988 $29.3m310.0k shares
INTUITIVE SURGICAL INC ISRG ISRG 32,305 $17.6m32.3k shares
INSULET CORP PODD PODD 51,408 $16.2m51.4k shares
TG THERAPEUTICS INC TGTX TGTX 447,884 $16.1m447.9k shares
GUARDANT HEALTH INC GH GH 302,307 $15.7m302.3k shares
BOSTON SCIENTIFIC CORP BSX BSX 138,834 $14.9m138.8k shares
RADNET INC RDNT RDNT 197,759 $11.3m197.8k shares
HEALTHEQUITY INC HQY HQY 80,880 $8.5m80.9k shares
ARS PHARMACEUTICALS INC SPRY SPRY 455,953 $8.0m456.0k shares
SOLENO THERAPEUTICS INC SLNO SLNO 86,332 $7.2m86.3k shares
ALNYLAM PHARMACEUTICALS INC ALNY ALNY 17,879 $5.8m17.9k shares
KALVISTA PHARMACEUTICALS INC KALV KALV 214,138 $2.4m214.1k shares
BETA BIONICS INC BBNX BBNX 157,194 $2.3m157.2k shares